Cargando…

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a highly aggressive and lethal form of liver cancer, and most patients with HCC die due to HCC-related causes. Although most patients die of HCC-related causes, non–HCC-related death represents a competing event among patients who engage in alcohol u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Yi-Hao, Kee, Kwong-Ming, Li, Wei-Feng, Liu, Yueh-Wei, Wang, Chih-Chi, Hu, Tsung-Hui, Tsai, Ming-Chao, Kuo, Yuan-Hung, Lin, Chih-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046416/ https://www.ncbi.nlm.nih.gov/pubmed/36980572 http://dx.doi.org/10.3390/cancers15061687

Ejemplares similares

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam
por: Nguyen-Dinh, Song-Huy, et al.
Publicado: (2022)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation
por: Yao, Chih-Chien, et al.
Publicado: (2023)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy
por: Huang, Pao-Yuan, et al.
Publicado: (2019)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients
por: Cho, Wei-Ru, et al.
Publicado: (2021)

Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death
por: Sheu, Ming-Jen, et al.
Publicado: (2021)

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery
por: Cho, Wei-Ru, et al.
Publicado: (2020)

Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study
por: Chen, Yen-Yang, et al.
Publicado: (2021)

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level
por: Yen, Yi-Hao, et al.
Publicado: (2018)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation
por: Kuo, Yuan-Hung, et al.
Publicado: (2023)

Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center
por: Liu, Yueh-Wei, et al.
Publicado: (2020)

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation
por: Hung, Chao-Hung, et al.
Publicado: (2017)

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West
por: Yen, Yi-Hao, et al.
Publicado: (2021)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral
por: Chang, Kuo-Chin, et al.
Publicado: (2022)

Low-dose nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis
por: Lin, Ming-Tsung, et al.
Publicado: (2016)

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data
por: Yen, Yi-Hao, et al.
Publicado: (2019)

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
por: Wang, Ming-Hung, et al.
Publicado: (2021)

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
por: Tsai, Ming-Chao, et al.
Publicado: (2021)

Laparoscopic Liver Resection Should Be a Standard Procedure for Hepatocellular Carcinoma with Low or Intermediate Difficulty
por: Gau, Ruoh-Yun, et al.
Publicado: (2021)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment
por: Yeh, Jen-Hao, et al.
Publicado: (2015)

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Hsu, Hsiao-Mei, et al.
Publicado: (2023)

Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
por: Chen, Yen-Yang, et al.
Publicado: (2020)

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation
por: Chen, Hsin-Yeh, et al.
Publicado: (2020)

Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up Study
por: Lin, Yen-Po, et al.
Publicado: (2022)

Time-course gait pattern analysis in a rat model of foot drop induced by ventral root avulsion injury
por: Chan, Shu-Yen, et al.
Publicado: (2022)

Stapleless laparoscopic left lateral sectionectomy for hepatocellular carcinoma: reappraisal of the Louisville statement by a young liver surgeon
por: Lee, Chao-Wei, et al.
Publicado: (2018)

Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jp659d8qqo17oojm9kf55oulbk